Trial Profile
The effect of ticagrelor on platelet function in patients with acute coronary syndrome undergoing elective percutaneous coronary intervention and carrying CYP2C19 loss-of-function polymorphisms.
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 27 Apr 2016
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary)
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- 27 Apr 2016 New trial record